Rumors Which In Turn Enzalutamide Brings To A Close, Obtain This Follow-Up

Матеріал з HistoryPedia
Перейти до: навігація, пошук

(5-7) The causes of death after ICU discharge and before hospital discharge and the factors that could influence these outcomes have not been studied yet. The present study aimed to assess the causes of death after ICU discharge and the characteristics of these patients when compared to patients who died in the ICU. METHODS The present is a pilot, retrospective, observational cohort study. The records of all patients admitted from February 1, 2013 to April 30, 2013 to two units with 20 and 23 beds, respectively, of a public/private university hospital Histone demethylase were assessed. That is, the data were from patients admitted to an ICU dedicated (but not exclusive) to patients from the Supplementary Health System (SHS) and another ICU dedicated to patients from the Public Health System (PHS). The study was approved by the Ethics and Research Committee (ERC) of the aforementioned Enzalutamide mw hospital under CAAE number 33417814.7.0000.5415. The need to obtain informed consent was waived by the ERC. Demographic and clinical data, risk scores and outcomes (discharge or death) were obtained from the Epimed Monitoring System and confirmed in the electronic record system of the hospital. The type of patient hospitalization was discriminated between PHS and SHS. The recorded causes of death were classified into 12 categories. All cases of patients who died in the hospital after being discharged from the first ICU hospitalization were considered deaths after ICU discharge, regardless of the place of death. For the statistical analysis, the Statistical Package for the Social Sciences (SPSS), version 11 was used. Categorical variables were addressed as proportions and analyzed by the chi-square test. Normally distributed continuous variables are presented as means and were evaluated by Student��s t test, whereas variables that were not normally distributed were evaluated by Mann-Whitney��s Venetoclax concentration test and are presented as medians. The Kolmogorov-Smirnov test was used to test for normality. To study risk factors, the relative risk (RR) was calculated and its respective confidence intervals (CI). A p value